Inhibrx Biosciences, Inc. Insider Transactions
Inhibrx Biosciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Kayyem Jon Faiz
Director |
Buy | 18,750 @ $14.19 | $266.10 K | 69,843 | 11/20/2024 | 11/22/2024 | |
|
Kayyem Jon Faiz
Director |
Buy | 34,843 @ $14.23 | $495.71 K | 51,093 | 11/19/2024 | 11/22/2024 | |
|
Vuori Kristiina MD
Director |
Buy | 6,667 @ $15.00 | $100.01 K | 20,443 | 10/03/2024 | 10/07/2024 | |
|
Lappe Mark
CEO |
Buy | 13,037 @ $17.13 | $223.32 K | 705,548 | 09/16/2024 | 09/16/2024 | |
|
Lappe Mark
CEO |
Buy | 26,963 @ $15.05 | $405.79 K | 692,511 | 09/12/2024 | 09/16/2024 | |
|
Vuori Kristiina MD
Director |
Buy | 6,457 @ $15.07 | $97.31 K | 13,776 | 09/11/2024 | 09/12/2024 | |
|
Vuori Kristiina MD
Director |
Buy | 179 @ $15.00 | $2.69 K | 7,319 | 09/10/2024 | 09/12/2024 | |
|
Lappe Mark
CEO |
Buy | 8,500 @ $15.19 | $129.12 K | 665,548 | 09/10/2024 | 09/10/2024 | |
|
Lappe Mark
CEO |
Buy | 9,500 @ $15.21 | $144.50 K | 657,048 | 09/09/2024 | 09/10/2024 | |
|
Lappe Mark
CEO |
Buy | 26,000 @ $15.29 | $397.54 K | 647,548 | 09/06/2024 | 09/10/2024 | |
|
Eckelman Brendan P.
Chief Scientific Officer |
Sell | 300,000 @ $34.30 | $10.29 M | 1,735,553 | 05/28/2024 | 05/30/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences, Inc. FAQ's
The list of insiders at Inhibrx Biosciences, Inc. includes Eckelman Brendan P., Lappe Mark, Vuori Kristiina MD, Kayyem Jon Faiz.
Insiders have sold a total of 300.00 K Inhibrx Biosciences, Inc. shares in the last 12 months for a total of 10.29 M sold.
The following insiders have sold Inhibrx Biosciences, Inc. shares in the last 12 months: Eckelman Brendan P. ($10.29 M),
Insiders have purchased a total of 150.90 K Inhibrx Biosciences, Inc. shares in the last 12 months for a total of 2.26 M.
The following insiders have purchased Inhibrx Biosciences, Inc. shares in the last 12 months: Lappe Mark ($1.30 M), Vuori Kristiina MD ($200.00 K), Kayyem Jon Faiz ($761.81 K),